Therefore, genetic variants that influence serum 25OHD, Ca and PTH levels could serve as instrumental variables (IVs) to determine the impact of serum 25OHD, Ca and PTH levels on the risk of CAD in patients with diabetes. This evidence concerns the gene PTH and coronary artery disorder.